O'masto vi saluta : Accogna la compagna!

[rez]

non vi sforzate a capire segnale fortissimo....
chiusura a rodosso dei 0.39

spero di sbagliarmi per difettissimo


BUONASERA A TUTTI CELLISTI :d

 

[Oldschool]

Comunque volevo fare notare che il titolo si è semplicemente riportato a valori su cui è stato dal luglio 2010. L'unica parentesi anomala è stata quando da metà febbraio a metà marzo si è portata sotto la linea dei 0,40$.Il fatto strano, se vogliamo, è stato il recupero violento del prezzo fatto registrare nella seconda metà di marzo, con volumi elevatissimi, mai scambiati nella storia di Cell; a mio avviso tutto ciò lascia pensare che siamo in attesa di qualche notizia veramente importante per la società, "very sensitive price" e pertanto molti hanno pensato bene di chiudere le loro posizioni al ribasso.
Ovviamente è solo una mia considerazione basata sul grafo e andamento del prezzo e volumi da luglio 2010 ad oggi.

 

[fly&dive]

50 ?
chi ha detto 50 ?
ho sentito 50 ?
aggiudicato 50 !!!!!!

 

[Lelc]

a colori

ecco trovato il posto dove incastrare la ruota della bici.

 

[zotica]

.....solo per augurare a Tutti una serena Pasqua.


Roberto

 

[Lelc]

ma af che fine a fatto, che bello oggi senza martellamenti nei marroni forse è statoBannato che serenità senza il piccolo affeffe.

 

[sergio65]

ma af che fine a fatto, che bello oggi senza martellamenti nei marroni forse è statoBannato che serenità senza il piccolo affeffe.

starà contando tutti i soldi guadagnati con lo short...forse....

 

[Matrix@36]

ragazzi,auguro una serena Pasqua a tutti.

 

[amedeo8]

starà contando tutti i soldi guadagnati con lo short...forse....

 

[diciottodieci]

Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV(R)'s Ready-to-Use Formulation (RTU)





Until Now FUSILEV® Has Been Available Only As A Lyophilized Product
FUSILEV® sNDA For Use In Advanced Metastatic Colorectal Cancer is Currently Under Review By The FDA
PDUFA Action Date — April 29, 2011
FUSILEV® Is Currently FDA Approved and Marketed by Spectrum For:
Rescue After High-Dose Methotrexate Therapy in Osteosarcoma;
To Diminish the Toxicity and Counteract the Effects of Impaired Methotrexate Elimination, and of Inadvertent Overdosage of Folic Acid Antagonists
IRVINE, Calif.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Supplemental New Drug Application for FUSILEV® (levoleucovorin) Injection. Unlike the currently available lyophilized product, this approval is for a "Ready-to-Use" formulation of FUSILEV® (levoleucovorin) for Injection.

"We are pleased that the FDA has approved the ‘Ready-to-Use' (RTU) formulation of FUSILEV®," said Rajesh C. Shrotriya, MD, Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals. "As the name implies, the RTU formulation provides an additional option for physician and medical staff use. The RTU formulation requires no reconstitution, and is of a higher strength than the currently available lyophilized formulation."

FUSILEV® (levoleucovorin) for Injection is currently FDA approved and marketed by Spectrum for rescue after high-dose methotrexate therapy in osteosarcoma. FUSILEV® is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination, and of inadvertent overdosage of folic acid antagonists. FUSILEV® is currently under review by the FDA for use in advanced metastatic colorectal cancer. The Prescription Drug User Fee Act (PDUFA) action date for the supplement is April 29, 2011.

 

[fly&dive]

rancho cell 2011

 

[fly&dive]

Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV(R)'s Ready-to-Use Formulation (RTU)





Until Now FUSILEV® Has Been Available Only As A Lyophilized Product
FUSILEV® sNDA For Use In Advanced Metastatic Colorectal Cancer is Currently Under Review By The FDA
PDUFA Action Date — April 29, 2011
FUSILEV® Is Currently FDA Approved and Marketed by Spectrum For:
Rescue After High-Dose Methotrexate Therapy in Osteosarcoma;
To Diminish the Toxicity and Counteract the Effects of Impaired Methotrexate Elimination, and of Inadvertent Overdosage of Folic Acid Antagonists
IRVINE, Calif.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Supplemental New Drug Application for FUSILEV® (levoleucovorin) Injection. Unlike the currently available lyophilized product, this approval is for a "Ready-to-Use" formulation of FUSILEV® (levoleucovorin) for Injection.

"We are pleased that the FDA has approved the ‘Ready-to-Use' (RTU) formulation of FUSILEV®," said Rajesh C. Shrotriya, MD, Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals. "As the name implies, the RTU formulation provides an additional option for physician and medical staff use. The RTU formulation requires no reconstitution, and is of a higher strength than the currently available lyophilized formulation."

FUSILEV® (levoleucovorin) for Injection is currently FDA approved and marketed by Spectrum for rescue after high-dose methotrexate therapy in osteosarcoma. FUSILEV® is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination, and of inadvertent overdosage of folic acid antagonists. FUSILEV® is currently under review by the FDA for use in advanced metastatic colorectal cancer. The Prescription Drug User Fee Act (PDUFA) action date for the supplement is April 29, 2011.

mercato pronto e reattivo

 

[Alessia85]

Buonasera.
Domani e' aperta la borsa Usa?

 

[fly&dive]

Buonasera.
Domani e' aperta la borsa Usa?

april 22 Good Friday Closed

 

[Alessia85]

april 22 Good Friday Closed

Grazie

Buonasera

 

[easymoney]

ma quando cavolo si ferma questo supereuro?

oggi siamo già oltre 1,46$

 

[LOROCIU65]

..un saluto a tutti..i cellisti...approvato .Fusilev,,Sppi..

..Toc Toc....

Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV®

 

[fly&dive]

..Toc Toc....

Spectrum Pharmaceuticals Announces FDA Approval of FUSILEV®

toc toc

da 9,75 a 9,33

 

[amedeo8]

ma quando cavolo si ferma questo supereuro?

oggi siamo già oltre 1,46$

http://www.pazzosognofinanza.com/public/4070.gif

 

[LOROCIU65]

toc toc

da 9,75 a 9,33

..15.000...da 5.35$...e aspetto il ventino.. anke tra 1 anno..